Category: Training Programs

ESGO 2022 – A great success

ESGO 2022 / Berlin Thank you, European Society of Gynaecological Oncology Berlin 2022. Several of NSGO-CTU PI’s attended the conference as speakers and guest. Mansoor Raza Mirza, NSGO-CTU’s Medical Director & Vice-President of ESGO had the honor of presenting the prestigious Helga Salvesen Award 🏆 for a major contribution in translational research to Prof Iain McNeish from the Imperial College […]

OReO/ENGOT-ov38 – IGCS22 / New York

OReO/ENGOT-ov38 PRO data from the phase 3b OReO/ENGOT-ov38 trial showed no significant effect on quality of life following rechallenge with maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer. International Gynecologic Cancer Society #IGCS2022 #gynsm #cancer #oncology arrow-icon-size3 Back To Overview

ENGOT meeting in Berlin, Sep. 2022

ENGOT meeting 15th annaversary Berlin, Sep. 2022 NSGO-CTU’s Medical Director, Dr. Mansoor Raza Mirza and Deputy Medical Director, Kristine Madsen attended the annual ENGOT meeting in Berlin last week. Dr. Mirza is currently Chair of ENGOT. Project Manager Christina Sidsel Dalsgaard and Mia Sejer Donner (NSGO-CTU ENGOT rep.) also attended the meeting with the ENGOT operationals. Previous Next arrow-icon-size3 Back To […]

Investigator Meeting 2022 – registration is open

Investigator meeting 2022 Copenhagen Registration for the NSGO-CTU Biannual Investigator Meeting in Copenhagen is now open! NSGO-CTU welcomes all members and other professionals with interest in gynaecological cancer research to the NSGO-CTU Biannual Investigator Meeting 24. – 25 of November, 2022 arrow-icon-size3 Register Now arrow-icon-size3 Back To Overview It is a long established fact that a […]


6th OCC – GCIG CONCESUS The consensus recommendation from the GCIG group for “Clinical research in ovarian cancer ” (from the 6th OCC) has been published. Line Bjørge, Mansoor R Mirza and Annika Auranen from NSGO-CTU contributed substantially to the publication. This will represent our guidelines for the upcoming years. #ovariancancer #ovariancanceravareness arrow-icon-size3 Back To Overview